ML23023A086
| ML23023A086 | |
| Person / Time | |
|---|---|
| Site: | SHINE Medical Technologies |
| Issue date: | 02/02/2023 |
| From: | Tanya Smith NRC/NMSS/DREFS/ERMB |
| To: | Wiggins M Bad River Band of Lake Superior Chippewa Indians |
| Shared Package | |
| ML23023A081 | List: |
| References | |
| Download: ML23023A086 (1) | |
Text
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Mike Wiggins, Jr, Chairman Bad River Band of Lake Superior Chippewa Indians P.O. Box 39 Odanah, WI 54861
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear Chairman Wiggins:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
M. Wiggins 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv Edith Leoso, THPO Signed by Smith, Theodore on 02/02/23
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 John Barrett, Chairman Citizen Potawatomi Nation 1601 S. Gordon Cooper Dr.
Shawnee, OK 74801
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear Chairman Barrett:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
J. Barret 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv Kelli Mosteller, THPO Citizen Potawatomi Nation 1899 South Gordon Cooper Drive Shawnee, OK 74801 Signed by Smith, Theodore on 02/02/23
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Anthony Reider, President Flandreau Santee Sioux Tribe of South Dakota 603 West Broad Avenue P.O. Box 238 Flandreau, SD 57208
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear President Reider:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
A. Reider 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv Garrie-Kills-A-Hundred, THPO Signed by Smith, Theodore on 02/02/23
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Ned Daniels Jr., Chairman Forest County Potawatomi Community 5416 Everybody's Rd.
P.O. Box 340 Crandon, WI 54520M
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear Chairman Daniels:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
N. Daniels 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv Benjamin Rhodd, THPO Signed by Smith, Theodore on 02/02/23
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Jeffrey Jeff Stiffarm, President Fort Belknap Indian Community 656 Agency Main Street RR 1, P.O. Box 66 Harlem, MT 59526
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear President Stiffarm:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
J. Stiffarm 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv Michael J. Black Wolf, THPO Signed by Smith, Theodore on 02/02/23
K.
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Kenneth Meshigaud, Chairperson Hannahville Indian Community N14911 Hannahville B-1 Rd.
Wilson MI 49896
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear Chairperson Meshigaud:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
K. Meshiguad 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv Earl Meshigaud, Director of Culture, Language and History Signed by Smith, Theodore on 02/02/23
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Marlon WhiteEagle, President Ho-Chunk Nation of Wisconsin P.O. Box 667 W9814 Airport Road Black River Falls, WI 54615
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear President White Eagle:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
M. WhiteEagle 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv William Quackenbush, THPO Signed by Smith, Theodore on 02/02/23
D.
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Perri Ahhaitty, Chairman Iowa Tribe of Oklahoma 335588 E. 750 Rd.
Perkins, OK 74059
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear Chairman Ahhaitty:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
P. Ahhaitty 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv Amy Scott Cultural Preservation Department Signed by Smith, Theodore on 02/02/23
P. Ahhaitty UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 John D. Johnson Sr., President Lac du Flambeau Band of Lake Superior Chippewa Indians 418 Little Pines Road P.O. Box 67 Lac du Flambeau, WI 54538
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear President Johnson:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
J.D. Johnson 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv Sarah Thompson, THPO Signed by Smith, Theodore on 02/02/23
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Regina Gasco Bentley, Chairman Little Traverse Bay Bands of Odawa Indians 7500 Odawa Circle Harbor Springs, MI 49740
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear Chairman Bentley:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
R. Gasco 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc w/encls:
Listserv Melissa Wiatrolik, THPO Signed by Smith, Theodore on 02/02/23
R.L. Larson UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Robert L. Larsen, President Lower Sioux Indian Community 39527 Res. Highway 1 P.O. Box 308 Morton, MN 56270
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear President Larsen:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
R.L. Larson 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv Cheyanne St. John, THPO Signed by Smith, Theodore on 02/02/23
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Ronald J. Corn Sr., Chairman Menominee Indian Tribe of Wisconsin W2908 Tribal Office Loop Road P.O. Box 910 Keshena, WI 54135
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear Chairman Corn:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
R.J. Corn 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc w/encls:
Listserv David Grignon, THPO Signed by Smith, Theodore on 02/02/23
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Douglas Lankford, Chief Miami Tribe of Oklahoma 3410 P St. NW P.O. Box 1326 Miami, OK 74355
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear Chief Lankford:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
D. Lankford 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv Diane Hunter, THPO Signed by Smith, Theodore on 02/02/23
D.
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Geoffrey Standing Bear, Chief Osage Nation 627 Grandview Pawhuska, OK 74056
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear Chief Standing Bear:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
G. Standing Bear 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv Andrea A. Hunter, THPO Signed by Smith, Theodore on 02/02/23
C. Harper UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Craig Harper, Chief Peoria Tribe of Indians of Oklahoma 118 S. Eight Tribes Trail P.O. Box 1527 Miami, OK 74355
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear Chief Harper:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
C. Harper 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv Logan Pappenfort Director of Cultural Preservation & NAGPRA Signed by Smith, Theodore on 02/02/23
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Joseph Zeke Rupnick, Chairperson Prairie Band of Potawatomi Nation 16281 Q Road Mayetta, KS 66509
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear Chairperson Rupnick:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
J. Rupnick 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv Signed by Smith, Theodore on 02/02/23
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Johnny Johnson, President Prairie Island Indian Community 5636 Sturgeon Lake Road Welch, MN 55089
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear President Johnson:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
J. Johnson 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv Noah White, THPO Signed by Smith, Theodore on 02/02/23
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Angela Gasper, Acting Principal Chief Sac and Fox Nation Administration Building 920883 S. Hwy 99, Bldg. A Stroud, OK 74079
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear Acting Principal Chief Gasper,
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
A. Gasper 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc w/encls:
Listserv Signed by Smith, Theodore on 02/02/23
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Roger Trudell, Tribal Chairman Santee Sioux Nation 108 Spirit Lake Ave. W.
Niobrara, NE 68760
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear Tribal Chairman Trudell:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
R. Trudell 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv Misty Frazier, THPO Santee Sioux Tribe of Nebraska 425 Frazier Ave. N. #2 Niobrara, NE 68760-7207 Signed by Smith, Theodore on 02/02/23
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 J. Garret Renville Tribal Chairman Sisseton-Wahpeton Oyate of the Lake Traverse Reservation 12554 BIA Hwy 711 P.O. Box 509 Agency Village, SD 57262
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear Tribal Chairman Renville:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
J.G. Renville 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv Dianne Desroisiers, THPO Signed by Smith, Theodore on 02/02/23
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Douglas Yankton Sr., Chairperson Spirit Lake Tribe 816 3rd Avenue North P.O. Box 359 Fort Totten, ND 58335
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear Chairperson Yankton:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
D. Yankton 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv Kenneth Graywater, THPO Spirit Lake Tribal Historic Preservation Office P.O. Box 198 Fort Totten, ND 58335 Signed by Smith, Theodore on 02/02/23
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 William Reynolds, Chairman St. Croix Chippewa Indians of Wisconsin St. Croix Tribal Center 24663 Angeline Ave.
Webster, WI 54893
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear Chairman Reynolds:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
W. Reynolds 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc w/encls:
Listserv Wanda McFaggan, THPO Signed by Smith, Theodore on 02/02/23
D.
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Kevin Jensvold, Chairman Upper Sioux Community 5722 Travers Lane P.O. Box 147 Granite Falls, MN 56241
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear Chairman Jensvold:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
K. Jensvold 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv Samantha Odegard, THPO Signed by Smith, Theodore on 02/02/23
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Victoria Kitcheyan, Chairwoman Winnebago Tribe of Nebraska 100 Bluff Street P.O. Box 687 Winnebago, NE 68071
SUBJECT:
NOTICE OF AVAILABILITY OF ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)
Dear Chairwoman Kitcheyan:
The U.S. Nuclear Regulatory Commission (NRC) has completed Supplement 1 to NUREG-2183, Environmental Impact Statement Related to the Operating License for the SHINE Medical Isotope Production Facility, regarding the SHINE Medical Technologies, LLC (SHINE) operating license application for the SHINE Medical Isotope Production Facility (SHINE facility). Supplement 1 to NUREG-2183 is being issued in accordance with the National Environmental Policy Act of 1969, as amended (42 U.S.C. 4321 et seq.) (NEPA), as part of the NRCs process to decide whether, under the provisions of title 10 of the Code of Federal Regulations part 50, to issue a license to SHINE to operate the SHINE facility for a period of 30 years.
By letter dated July 8, 2022, the NRC submitted a copy of the draft of Supplement 1 to NUREG-2183 to your office. As discussed in our July 8, 2022 letter, the NRC is complying with Section 106 of the National Historic Preservation Act of 1966, as amended (NHPA),
through the NEPA process in accordance with 36 CFR 800.8(c). As documented in the draft of Supplement 1 to NUREG-2183, in the context of NEPA, the NRC determined that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC determined that there would be no effect to historic properties. In finalizing Supplement 1 to NUREG-2183, the NRC did not identify any new information that would change these findings.
A copy of Supplement 1 to NUREG-2183 is available via the following link:
https://www.nrc.gov/docs/ML2302/ML23026A312.pdf. This document is also available through the web-based version of the NRCs Agencywide Documents Access and Management System at https://www.nrc.gov/readingrm/adams.html under ML23026A312.
February 2, 2023
V. Kitcheyan 2
Should you have any questions, please contact Lance Rakovan, Senior Project Manager, by telephone at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.
Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 cc:
Listserv Sunshine Thomas-Bear, THPO Signed by Smith, Theodore on 02/02/23
ML23023A086 OFFICE NMSS/REFS/ELRB NMSS/REFS/EMRB NMSS/REFS/ELRB NMSS/REFS/ELRB NAME NMartinez AWalker-Smith LRakovan TSmith DATE 2/01/2023 2/01/2023 2/2/2023 2/2/2023